CONMED CORPORATION Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax
CONMED CORPORATION (CNMD) reported Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax of $15.17 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax · last filed 2026-02-17
- CONMED CORPORATION other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax for fiscal 2025 was $15.17M.
- CONMED CORPORATION other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax for fiscal 2024 was -$14.75M, a 390.13% decline from fiscal 2023.
- CONMED CORPORATION other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax for fiscal 2023 was $5.08M.
- CONMED CORPORATION other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax for fiscal 2022 was -$8.42M.
| Period end | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax 12 month |
|---|---|
| 2025-12-31 | $15.17M 10-K · filed 2026-02-17 |
| 2024-12-31 | -$14.75M 10-K · filed 2026-02-17 |
| 2023-12-31 | $5.08M 10-K · filed 2026-02-17 |
| 2022-12-31 | -$8.42M 10-K · filed 2025-02-18 |
| 2021-12-31 | -$7.07M 10-K · filed 2024-02-28 |
| 2020-12-31 | $6.96M 10-K · filed 2023-02-21 |
| 2019-12-31 | $25.00K 10-K · filed 2022-02-22 |
| 2018-12-31 | -$8.37M 10-K · filed 2021-02-22 |
| 2017-12-31 | $13.88M 10-K · filed 2020-02-24 |
| 2016-12-31 | -$4.50M 10-K · filed 2019-02-25 |
| 2015-12-31 | -$16.77M 10-K · filed 2018-02-26 |
| 2014-12-31 | -$15.07M 10-K · filed 2017-02-27 |
| 2013-12-31 | -$1.19M 10-K · filed 2016-02-23 |
| 2012-12-31 | $2.00M 10-K · filed 2015-02-23 |
| 2011-12-31 | -$1.94M 10-K · filed 2014-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |